Vanderbilt. US: The Lustgarten Foundation has awarded a $1.5 million Research
Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry,
Pharmacology and Chemistry, for research designed to discover new drugs
for the treatment of pancreatic cancer. This is Fesik’s second three-year award from the Lustgarten
Foundation in support of his research targeting K-Ras, a protein mutated
in 90 percent of pancreatic cancer cases, as well as other forms of
cancer.Fesik is among 13 scientists nominated by their peers for
significant achievements in the field of pancreatic cancer research who
will receive a total of $19.5 million in research funding from the
foundation.